Peter Riedell

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AbbVie
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    ADC Therapeutics
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Kite/Gilead
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sana Biotechnology
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Nektar Therapeutics
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Intellia Therapeutics
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    CVS Caremark
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genmab
    Date added:
    09/18/2024
    Date updated:
    09/18/2024

Pages

Return to Chicago Cellular Therapy in Hematology and Oncology: Expert Guidance for Clinical Practice